Current Tri-Institutional MD-PhD student, Maria Passarelli, has been awarded an F30 Fellowship from the National Institutes of Health's National Cancer Institute.
Dr. M. Elizabeth Ross, MD, PhD, member of the Tri-Institutional MD-PhD graduating class of 1982, is a co-senior author on a recent Nature Genetics paper identifying a genetic cause for a "mosaic" disorder. This heretofore poorly understood disorder causes abnormalities in the skin, brain, and beyond.
As we announced last year, the Tri-Institutional MD-PhD Program founded a "House System." This MD-PhD student-led initiative has the goal of fostering mentorship and community within and across the Program.
The summer of 2019 saw a record 16 Gateways students. They came from across the country to spend 10 weeks working in labs at all three of our institutions (plus one at HSS), doing clinical shadowing, participating in clinical problem based lab discussions led by current MD-PhD students, and volunteering in the Heart to Heart Community Clinic.
With another three interview days behind us (two in October and the last one just recently on November 21), we are waist deep in the 2020 admissions cycle. With 90 applicants representing 43 colleges and universities invited to interview over the three days, it has been an exciting interview season here at the Tri-I. We were honored to welcome this multi-talented group of students to our campus.
A total of ten Gateways alumni presented their research at the 2019 Annual Biomedicine Research Conference for Minority Students (ABRCMS). Held from November 13th through the 16th in Anaheim, California, the conference saw attendance of more than 5,000 undergraduates, graduate students, and researchers.
In a study published in Nature on October 23, Conor Liston, MD, PhD, and his collaborators present new results, using mouse models, on the effects of depleted gut microbiota on the brain.
Dr. Randy Longman, MD, PhD, (Tri-I MD-PhD graduating class of 2007) has been named as the new Director of the Jill Roberts Center for Inflammator Bowel Disease at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center.
